A purified polysaccharide from Dictyophora rubrovolvata volva: Physicochemical properties, structure and anti-inflammatory activity
This study characterizes a novel 14.15 kDa heteropolysaccharide (DRVP-1) isolated from *Dictyophora rubrovolvata* volva, elucidating its specific monosaccharide composition and glycosidic linkages while demonstrating its significant anti-inflammatory activity in LPS-stimulated macrophages via the suppression of the NF-κB signaling pathway.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Inflammation is the body's urgent, noisy response to injury or infection, a biological alarm system designed to clear threats and begin repair. When this system works correctly, it is a temporary shield; when it runs out of control, however, it becomes a source of chronic damage, fueling a wide range of serious diseases. Nature has long offered a library of compounds to help calm this overreaction, many of which come from the fungal kingdom. These organisms, often overlooked as mere decomposers, produce complex sugar chains known as polysaccharides. These molecules are not simple sugars like table sugar, but rather long, intricate strings of different sugar units linked together, capable of interacting with the immune system in sophisticated ways. Because they are generally safe and non-toxic, scientists are increasingly turning to fungi to find new, gentle ways to manage inflammatory conditions without the harsh side effects of synthetic drugs.
In a recent study, researchers turned their attention to a specific fungus called Dictyophora rubrovolvata, a species found in the forests of China that resembles a small, red-capped umbrella. While the main fruiting body of this fungus is harvested for food and medicine, a part of it called the volva—the cup-like structure at the base—is typically discarded as waste. This byproduct, often left to rot at harvest sites, represents a lost opportunity. A team of scientists from Hefei University of Technology decided to investigate whether this discarded material held hidden value. They set out to extract a specific polysaccharide from the volva, map out its exact chemical structure, and test whether it could effectively soothe the overactive immune cells that drive inflammation.
The researchers began by processing the dried volva, washing it to remove impurities and then extracting the water-soluble components. Through a series of careful purification steps involving special columns that separate molecules by size and charge, they isolated a single, pure substance they named DRVP-1. This molecule weighed 14.15 kilodaltons, a size that suggests it is small enough to move easily through biological systems. Chemical analysis revealed that DRVP-1 is a heteropolysaccharide, meaning it is built from a mix of four different types of sugar units: glucose, galactose, mannose, and fucose. In the final mixture, galactose was the most abundant, making up about 41 percent of the structure, followed by glucose at nearly 35 percent, with mannose and fucose making up the remainder.
To understand how these sugars were connected, the team examined the molecule's shape and links using a variety of advanced imaging and spectroscopy tools. They found that the molecule did not form a rigid triple-helix structure, a shape often associated with anti-tumor properties, but instead formed a flexible, cross-linked network. The backbone of the molecule was a complex chain of glucose and galactose units, with branches of mannose and fucose sticking out at specific points. This intricate architecture, with its mix of straight chains and side branches, is likely what allows the molecule to interact with the immune system. The study confirmed that the substance was free of proteins and nucleic acids, ensuring that any biological effects observed were due to the sugar structure itself.
The true test of DRVP-1 came when the researchers exposed it to immune cells known as macrophages, which act as the body's first responders to infection. In the lab, these cells were triggered into a state of high alert using a substance that mimics a bacterial infection, causing them to flood the environment with inflammatory signals. When the researchers introduced DRVP-1 to these agitated cells, the substance acted as a brake. It significantly reduced the production of nitric oxide and reactive oxygen species, two aggressive chemicals that cells release during inflammation that can damage surrounding tissue. Furthermore, the cells released far lower levels of inflammatory messengers, specifically proteins called TNF-alpha, IL-6, and IL-1-beta, which are responsible for spreading the inflammatory signal throughout the body.
To understand how this calming effect worked, the team looked inside the cells to see which internal switches were being flipped. They focused on a well-known pathway called NF-kappaB, a master regulator that turns on the genes responsible for inflammation. In the inflamed cells, this pathway was highly active, but the presence of DRVP-1 dampened its activity, effectively stopping the signal before it could trigger a full-blown immune response. The study showed that the polysaccharide did this without harming the cells themselves; even at high concentrations, the cells remained healthy and active. This suggests that the molecule targets the specific machinery of inflammation rather than simply suppressing the cell's general function.
The findings offer a new perspective on the potential of agricultural waste. By transforming the discarded volva of Dictyophora rubrovolvata into a purified, bioactive substance, the researchers demonstrated that what was once considered trash could be a valuable resource for health. While the study confirms that this specific polysaccharide has strong anti-inflammatory properties and identifies the likely pathway it uses, the researchers note that the full picture of how it works and how it might be used in humans still requires further investigation. For now, the work stands as a clear example of how detailed chemical analysis can reveal hidden potential in nature, turning a simple byproduct into a promising candidate for future therapeutic development.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.